Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease
Clinical trial NCT00304629 · COMPLETED
Trial details
- NCT number
- NCT00304629
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-03-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.